A preliminary review by the Food and Drug Administration determined that Aerie Pharmaceuticals Inc.'s (Nasdaq: AERI) Rhopressa lowered eye pressure sending the stock price soaring $8.95 to close at $64.30.
Aerie Pharmaceutical's Rhopressa lowers eye pressure
October 11, 2017 at 17:32 PM EDT
